Viewing Study NCT02294357


Ignite Creation Date: 2025-12-24 @ 6:37 PM
Ignite Modification Date: 2025-12-29 @ 4:10 PM
Study NCT ID: NCT02294357
Status: TERMINATED
Last Update Posted: 2023-11-01
First Post: 2014-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
Sponsor: Oncotherapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module